Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astera Labs (ALAB) Total Liabilities (2023 - 2026)

Astera Labs has reported Total Liabilities over the past 3 years, most recently at $168.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities rose 87.48% year-over-year to $168.2 million, compared with a TTM value of $168.2 million through Dec 2025, up 87.48%, and an annual FY2025 reading of $168.2 million, up 87.48% over the prior year.
  • Total Liabilities came in at $168.2 million for Q4 2025, up from $129.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $168.2 million in Q4 2025 to a low of $38.9 million in Q4 2023.
  • Median Total Liabilities over the past 3 years was $96.7 million (2023), compared with a mean of $99.6 million.
  • The largest YoY upside for Total Liabilities was 130.82% in 2024 against a maximum downside of 43.85% in 2024.
  • Over 3 years, Total Liabilities stood at $38.9 million in 2023, then surged by 130.82% to $89.7 million in 2024, then soared by 87.48% to $168.2 million in 2025.
  • Per Business Quant, the three most recent readings for ALAB's Total Liabilities are $168.2 million (Q4 2025), $129.5 million (Q3 2025), and $135.7 million (Q2 2025).